cervical cancer and uterine cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Women who are 20 years old at the time of giving informed consent. 2. Patient with clinical stage I – II cervical cancer or patients who are supposed to have surgical stage I – III uterine cancer (cervical cancer is staged before treatment and uterine cancer is staged after surgery by histo-pathological examination). 3.PS: 0 – 1 4. Patients who have been given information and who have discussed the risks, benefits and other aspects of the trial with principal investigator and who provide voluntary consent by signing the written informed consent documents.
Exclusion criteria
Exclusion criteria: 1. Patient with cervical or uterine cancer with specific subtype of undifferentiated carcinoma, small cell carcinoma, clear cell adenocarcinoma, glassy cell carcinoma. 2. Patients who are judged to be not eligible for the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Operation time, console time, blood loss, intra-operative/post-operative complications will be recorded, which will be compared to those of open surgery for cervical and uterine cancers. | — |
Secondary
| Measure | Time frame |
|---|---|
| Histopathological completeness of surgery, number of lymph nodes harvested, post-operative bladder function, 5-year recurrence free survival and the site of recurrence. | — |
Countries
Japan
Contacts
Hokkaido University Graduate School of Medicine Department of Gynecology